IL0010807530
IL0010807530
ILEX MEDICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 513.87M EUR | 54.77B EUR | 68.49B EUR | 74.58B EUR |
Enterprise Value | 343.24M EUR | 54.63B EUR | 68.36B EUR | 74.45B EUR |
Valuation Multiples | ||||
Trailing P/E | 13.2x | 1,407.72x | 1,333.55x | 1,605.8x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 0.58x | 61.86x | 75.59x | 107.69x |
Price to Book | 76.48x | 81.72x | 102.79x | 108.92x |
EV/Revenue | 0.39x | 61.71x | 75.44x | 107.5x |
EV/EBITDA | 4.55x | 579.33x | 615.46x | 806.84x |
Price to FCF (P/FCF) | 16.61x | 1,189.01x | 1,214.75x | 2,231.66x |
EV/FCF | 11.1x | 1,186.09x | 1,212.35x | 2,227.8x |
FCF Yield | 6.02% | 0.08% | 0.08% | 0.04% |